Results 111 to 120 of about 29,938 (169)

Sustained salivary IgG but short-lived IgA responses following primary and booster MenACWY-TT vaccination in older adults. [PDF]

Hum Vaccin Immunother
Visser M, van Rooijen DM, Wolf J, Beckers L, de Jonge MI, Buisman A, den Hartog G.   +6 more
europepmc   +1 more source

Neisseria meningitidis serogroup B causing invasive disease, Italy, 2010-2021. [PDF]

PLoS One
Vacca P, Vescio F, D'Ancona F, Fazio C, Neri A, Carannante A, Ambrosio L, Lista FR, Fillo S, Ciammaruconi A, Fortunato A, Stefanelli P.   +11 more
europepmc   +1 more source

Purpura Fulminans Due to Neisseria meningitidis Septicemia Treated With Adjunctive Hyperbaric Oxygen Therapy: A Case Report. [PDF]

Cureus
Bani Hammad N, Alghatam A, Aljalahma J, Albuainain N.   +3 more
europepmc   +1 more source

Invasive meningococcal disease in adolescents in Europe and select geographies: Disease burden, unmet medical need, and optimizing prevention. [PDF]

Hum Vaccin Immunother
Andani A, Abbing-Karahagopian V, Kavaliauskaite J, Schaffner TO, Sohn WY, Graña MG, Marshall H, Martinon-Torres F, Bonanni P, Rappuoli R, Taha MK.   +10 more
europepmc   +1 more source

Meningococcal Serogroup Y Meningitis Reveals Inborn Factor B Deficiency. [PDF]

Eur J Immunol
Bougeard C, Eskander E, Martins PV, Bitan J, Roquigny J, Kyheng C, Guiddir T, Frémeaux-Bacchi V, Gonnin C, ElSissy C.   +9 more
europepmc   +1 more source

Outbreak of invasive meningococcal disease caused by a meningococcus serogroup B expressing a rare <i>porA</i> genosubtype (19-54, 15), Spain, March to April 2024. [PDF]

Euro Surveill
Abad R, Navarro C, García-Amil C, Montes M, Castañeda-García A, Cuadros JA, Galar A, Martin F, Mena E, Pérez de Madrid S, Román C, Soler M, Vázquez JA.   +12 more
europepmc   +1 more source

Invasive Meningococcal Disease in the Post-COVID-19 Era in South America. [PDF]

Vaccines (Basel)
Sáfadi MAP, Falconi JF, Abalos MG, Serra L, Gentile A, Diaz A, Cortes CP, Villena R.   +7 more
europepmc   +1 more source

Modelling the epidemiological impact and cost-effectiveness of possible changes to the meningococcal vaccination schedule for adolescents and young adults in the United States. [PDF]

BMC Public Health
Shin T, Cristeau O, Upegui A, Neary MP, Robertson CA, Galarza K, Clay E, Wu J.   +7 more
europepmc   +1 more source

Beyond the Central Nervous System: Neisseria meningitidis as an Unusual Cause of Urogenital Infection. [PDF]

Cureus
Alhetheel F, Alazmi BA, Alshammari BS, Alhetheel AF.   +3 more
europepmc   +1 more source